The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast
The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy sub-specialties.
Episodes
7 days ago
7 days ago
In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, and guest Rosa Malloy-Post, MD, delve into the debate over the most suitable paralyzing agent for rapid sequence intubation (RSI). They weigh the advantages and disadvantages of Succinylcholine ("Succ") and Rocuronium ("Roc") by comparing their pharmacologic properties, onset, duration, side effects, and clinical use cases. Listen for expert perspectives, practical insights, and essential factors to consider when choosing the right agent in emergency settings, and find out if "Roc truly rocks" or if "Succs really suck.
Tuesday Aug 13, 2024
Tuesday Aug 13, 2024
In this episode, host Jimmy L. Pruitt III, PharmD, BCPS, BCCCP, BCEMP, welcomes Tessa R. Cox, PharmD, BCCCP, and Brian W. Gilbert, PharmD, MBA, FCCM, FNCS, BCCCP, to discuss their study on the early administration of subcutaneous (SQ) basal insulin in mild to moderate diabetic ketoacidosis (DKA). The episode covers the definition and treatment of DKA, the role of insulin therapy, and the design and results of the retrospective study, which found no significant difference in hospital length of stay between early and non-early SQ basal insulin groups. The discussion includes an analysis of the study outcomes, clinical implications, and the need for further research. Tessa R. Cox and Brian W. Gilbert share their expert insights on DKA management and the relevance of the study findings to emergency medicine.
Monday Jul 15, 2024
Monday Jul 15, 2024
Amazon Link: https://www.amazon.com/InteGREAT-Guidebook-Creating-Healthcare-Teams/dp/1946665706In this episode, Jimmy Pruitt engages with the C3 Group authors, Andrea Sikora, Anthony Hawkins, and Susan Smith from the University of Georgia College of Pharmacy. They delve into their collaborative journey of writing the book InteGREAT: A Guidebook for Creating Great Healthcare Teams. The discussion covers the challenges, milestones, and pivotal moments experienced during the book's creation. They explore the vision and goals behind the book, its structure, and how it aids in building and optimizing healthcare teams. The authors share insights on the importance of team development, building relationships, leveraging individual strengths, and achieving alignment within the team. The episode also highlights how the book impacts clinical teams and the authors' professional activities.Show notes: https://pharm-so-hard.com/2024/07/02/episode-116-collaborative-insights-on-creating-great-healthcare-teams-with-c3-group-authors/
Tuesday May 07, 2024
Tuesday May 07, 2024
This episode of the Pharm So Hard podcast discusses the use of clinical pharmacy practitioners in the emergency room and their impact on sepsis antibiotic interventions author by Aubrie Hammond, Regan Porter, Taylor Cason, et al. The study found that the involvement of EMCPPs significantly improved the selection and timing of antibiotic administration in septic patients. The pharmacist-driven protocol improved the rate of appropriate antibiotic selection from 57% to 86% and reduced the time to administration by 64 minutes. The study also highlighted areas where antibiotic selection could be further improved, such as UTIs and intra-abdominal infections. The role of pharmacists in optimizing treatment time and expanding the pharmacist-driven sepsis management model was also discussed.
Monday Apr 22, 2024
Monday Apr 22, 2024
In this episode of the Pharm So Hard Podcast's PharmD Literature Highlight Series, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP discusses the study "Risk of arrhythmia in post-resuscitative shock after out-of-hospital cardiac arrest with epinephrine versus norepinephrine" by Sarah Normand, Pharm.D., Courtney Matthews, Pharm.D., Caitlin S. Brown, Pharm.D., Alicia E. Mattson, Pharm.D., Kristin C. Mara, M.S., Fernanda Bellolio, M.D., M.S., and Erin D. Wieruszewski, Pharm.D.
Tuesday Apr 16, 2024
Tuesday Apr 16, 2024
Full TextPubMedIn this episode of the Pharm So Hard podcast, host Jimmy Pruitt interviews Brock Townsend and Brian Gilbert about their study on the impact of time to administration of four-factor PCC for patients with warfarin-associated intracranial hemorrhage. The study was a retrospective observational single-center study performed at a large community teaching hospital. The authors stratified patients into three groups based on time from diagnosis to administration of four-factor PCC. The study found no significant differences in outcomes, such as hemostasis achievement, hospital mortality, length of stay, and adverse effects. The authors emphasize the need for more data and personalized protocols for anticoagulation-related ICH.
Takeaways
The study found no significant differences in outcomes based on time to administration of four-factor PCC for patients with warfarin-associated intracranial hemorrhage. More data is needed to determine the optimal time to administer four-factor PCC and develop personalized protocols for anticoagulation-related ICH.
Standardization of radiologists' interpretations and reporting of CT scans is important for future studies in this area.
The study highlights the importance of resident research in answering important clinical questions.
Pharmacists and healthcare professionals should continue to strive for personalized medicine and individualized care for patients with anticoagulation-related ICH.
Friday Mar 08, 2024
Friday Mar 08, 2024
In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, alongside guests Robert O'Connell, PharmD, BCCCP, BCEMP, Louisa Sullivan, PharmD, BCPS, BCEMP, Mark Mixon, PharmD, BCPS, BCIDP, BCCCP, and Joshua Senn, PharmD, BCPS, share their experiences at last year's EMPoweRx conference. As they gear up for this year's conference, gain exclusive insights into their preparations and aspirations, offering a glimpse into their pursuit of excellence in pharmacy practice.
Thursday Feb 15, 2024
Thursday Feb 15, 2024
This Pharm So Hard episode titled "Pulse Check! Kyle Stupca's Study on Esmolol & Dose-Capped Epi" is a deep dive into the innovative research conducted by Kyle Stupca on emergency cardiac care. The episode hosted by Jimmy Pruitt aims to explore Stupca's groundbreaking study which focuses on the use of Esmolol and dose-capped epinephrine in treating life-threatening cardiac arrhythmias like ventricular fibrillation and pulseless ventricular tachycardia. The discussion covers Stupca's personal journey and motivations in emergency medicine research, delves into the specifics of his study's methodology, findings, and the challenges faced during research. A significant part of the episode is dedicated to discussing the practical implications of these findings for emergency cardiac care and envisaging the future of this field with unlimited research resources. This episode is designed to enlighten healthcare professionals, particularly pharmacists and physicians, about the evolving role of pharmacology in emergency medical scenarios, emphasizing the critical impact of research in this domain.
Tuesday Oct 17, 2023
Tuesday Oct 17, 2023
In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Alexandra Cruz Pabón, PharmD and Nicholas Servati, PharmD, BCCP discuss the STREAM-2 Study Journal Club.
Tuesday Oct 10, 2023
Tuesday Oct 10, 2023
In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Rosa Malloy-Post, MD discuss the use of Methylene Blue for Refractory Hypotension.